Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esab (ESAB) Cash & Equivalents (2021 - 2025)

Esab (ESAB) has disclosed Cash & Equivalents for 5 consecutive years, with $185.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 25.46% to $185.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $185.9 million, a 25.46% decrease, with the full-year FY2025 number at $185.9 million, down 25.46% from a year prior.
  • Cash & Equivalents was $185.9 million for Q4 2025 at Esab, down from $218.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $291.3 million in Q2 2025 to a low of $41.2 million in Q4 2021.
  • A 5-year average of $140.4 million and a median of $82.8 million in 2023 define the central range for Cash & Equivalents.
  • Biggest YoY gain for Cash & Equivalents was 280.87% in 2025; the steepest drop was 25.46% in 2025.
  • Esab's Cash & Equivalents stood at $41.2 million in 2021, then skyrocketed by 74.78% to $72.0 million in 2022, then surged by 41.62% to $102.0 million in 2023, then soared by 144.46% to $249.4 million in 2024, then dropped by 25.46% to $185.9 million in 2025.
  • Per Business Quant, the three most recent readings for ESAB's Cash & Equivalents are $185.9 million (Q4 2025), $218.2 million (Q4 2025), and $258.2 million (Q3 2025).